|
CN107119135A
|
|
Purposes of the SLC2A4RG genes in diagnosing ankylosing spondylitis
|
|
CN107119136A
|
|
The diagnosis marker of ankylosing spondylitis
|
|
CN106868204A
|
|
A kind of biomarker for sdenocarcinoma of stomach diagnosis
|
|
CN106947820A
|
|
Purposes of the VCAN in adenocarcinoma of colon diagnosis and treatment
|
|
CN106947819A
|
|
Adenocarcinoma of colon diagnosis and treatment mark
|
|
CN106947821A
|
|
Biomarker for diagnosis and treatment adenocarcinoma of colon
|
|
CN106947818A
|
|
A kind of molecular marker of diagnosis and treatment adenocarcinoma of colon
|
|
CN106729756A
|
|
Application of the biomarker as target in adenocarcinoma of lung diagnosis and treatment
|
|
CN106755427A
|
|
Applications of the OTOF in Bgudd-Chiari Syndrome diagnosis
|
|
CN106755426A
|
|
Purposes of the IFI27 in diagnosis Bgudd-Chiari Syndrome product is prepared
|
|
CN106755372A
|
|
A kind of application of molecular marker in OSCC is diagnosed and is treated
|
|
CN106755373A
|
|
Applications of the LMOD3 in oral squamous cell carcinomas diagnosis and treatment preparation is prepared
|
|
CN106520992A
|
|
Application of molecular marker STAC2 to oral squamous cell carcinoma
|
|
CN106244705A
|
|
ERC1 application in preparation diagnosis or treatment hypopharyngeal cancer instrument
|
|
CN106381329A
|
|
C18orf8 gene and expression product thereof taken as diagnosis and treatment target for hypopharyngeal carcinoma
|
|
CN106244686A
|
|
The new application of mir 3620
|
|
CN106244688A
|
|
A kind of mark assessing adenocarcinoma of colon risk
|
|
CN106244680A
|
|
The application in diagnosis of disease of ORC1L gene and expression product thereof
|
|
CN106244684A
|
|
A kind of molecular target of esophageal squamous cell carcinoma
|
|
CN105925714A
|
|
Molecular marker for diagnosing cerebral ischemic thrombosis
|
